Table of Contents
ISRN Microbiology
Volume 2012 (2012), Article ID 215275, 6 pages
http://dx.doi.org/10.5402/2012/215275
Research Article

Genetic Characterization of Methicillin Resistant and Sensitive, Vancomycin Intermediate Staphylococcus aureus Strains Isolated from Different Iranian Hospitals

1Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, P.O. Box 73461-8174, Isfahan, Iran
2Department of Medical Biotechnology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center, Tehran, Iran
4Department of Microbiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
5Food and Drug Laboratory Research Center, Ministry of Health and Medical Education, No. 408, Emam Khomeini Avenue, Tehran, Iran
6Reference Health Laboratories, Ministry of Health and Medical Education, Tehran, Iran
7Department of Epidemiology, School of Medicine, Isfahan University of Medical Sciences, P.O. Box 73461-8174, Isfahan, Iran

Received 5 November 2012; Accepted 22 November 2012

Academic Editors: C. K. Cote, P. Di Martino, S. H. Flint, and G. Koraimann

Copyright © 2012 Seyed Asghar Havaei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Rehm and A. Tice, “Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus,” Clinical Infectious Diseases, vol. 51, no. 2, pp. S176–S182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Sievert, J. T. Rudrik, J. B. Patel, L. C. McDonald, M. J. Wilkins, and J. C. Hageman, “Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006,” Clinical Infectious Diseases, vol. 46, no. 5, pp. 668–674, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Hiramatsu, H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover, “Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility,” Journal of Antimicrobial Chemotherapy, vol. 40, no. 1, pp. 135–136, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. T. R. Walsh and R. A. Howe, “The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus,” Annual Review of Microbiology, vol. 56, pp. 657–675, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Ploy, C. Grélaud, C. Martin, L. De Lumley, and F. Denis, “First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital,” Lancet, vol. 351, no. 9110, article 1212, 1998. View at Google Scholar · View at Scopus
  6. G. A. Oliveira, A. M. Dell'Aquila, R. L. Masiero et al., “Isolation in Brazil of nosocomial Staphylococcus aureus With reduced susceptibility to vancomycin,” Infection Control and Hospital Epidemiology, vol. 22, no. 7, pp. 443–448, 2001. View at Google Scholar · View at Scopus
  7. M.-N. Kim, C. H. Pai, J. H. Woo, J. S. Ryu, and K. Hiramatsu, “Vancomycin-intermediate Staphylococcus aureus in Korea,” Journal of Clinical Microbiology, vol. 38, no. 10, pp. 3879–3881, 2000. View at Google Scholar · View at Scopus
  8. S. K. Fridkin, “Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know,” Clinical Infectious Diseases, vol. 32, no. 1, pp. 108–115, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. S. K. Pillai, C. Wennersten, L. Venkataraman, G. M. Eliopoulos, R. C. Moellering, and A. W. Karchmer, “Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus,” Clinical Infectious Diseases, vol. 49, no. 8, pp. 1169–1174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Aligholi, M. Emaneini, F. Jabalameli, S. Shahsavan, H. Dabiri, and H. Sedaght, “Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini hospital in Tehran,” Medical Principles and Practice, vol. 17, no. 5, pp. 432–434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. CDC, “Public Health Dispatch: vancomycin-resistant Staphylococcus aureus—Pennsylvania,” Morbidity and Mortality Weekly Report, vol. 51, no. 40, p. 902, 2002. View at Google Scholar
  12. S. Chang, D. M. Sievert, J. C. Hageman et al., “Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene,” New England Journal of Medicine, vol. 348, no. 14, pp. 1342–1347, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Dezfulian, M. M. Aslani, M. Oskoui et al., “Identification and characterization of a high vancomycin-resistant Staphylococcus aureus harboring VanA gene cluster isolated from diabetic foot ulcer,” Iranian Journal of Basic Medical Sciences, vol. 15, no. 2, pp. 803–806, 2012. View at Google Scholar
  14. M. Kacica and L. McDonald, “Brief Report: vancomycin-resistant Staphylococcus aureus—New York,” Morbidity and Mortality Weekly Report, vol. 53, no. 15, pp. 522–523, 2004. View at Google Scholar
  15. D. Miller, V. Urdaneta, A. Weltman, and S. Park, “Vancomycin-resistant Staphylococcus aureus,” Morbidity and Mortality Weekly Report, vol. 51, p. 902, 2002. View at Google Scholar
  16. B. Saha, A. K. Singh, A. Ghosh, and M. Bal, “Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia),” Journal of Medical Microbiology, vol. 57, no. 1, pp. 72–79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Thati, C. T. Shivannavar, and S. M. Gaddad, “Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad,” Indian Journal of Medical Research, vol. 134, no. 5, pp. 704–708, 2011. View at Google Scholar
  18. H. K. Tiwari and M. R. Sen, “Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India,” BMC Infectious Diseases, vol. 6, article 156, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. L. M. Weigel, R. M. Donlan, D. H. Shin et al., “High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 1, pp. 231–238, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. S. Naimi, D. Anderson, C. O'Boyle et al., “Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia,” Clinical Infectious Diseases, vol. 36, no. 12, pp. 1609–1612, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. J. C. Hageman, D. A. Pegues, C. Jepson et al., “Vancomycin-intermediate Staphylococcus aureus in a home health-care patient,” Emerging Infectious Diseases, vol. 7, no. 6, pp. 1023–1025, 2001. View at Google Scholar · View at Scopus
  22. S. Bobin-Dubreux, M. E. Reverdy, C. Nervi et al., “Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 1, pp. 349–352, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. P. A. Wayne, “Performance standards for antimicrobial susceptibility testing,” CLSI document M100-S20, 20th informational supplement. Clinical Laboratory Standard Institute, 2010.
  24. P. A. Wayne, “Performance standards for antimicrobial disk susceptibility tests,” CLSI document M02-A11, 11th ed. Clinical Laboratory Standard Institute, 2012.
  25. K. Boye, M. D. Bartels, I. S. Andersen, and J. A. Møller, “A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I–V,” Clinical Microbiology and Infection, vol. 13, no. 7, pp. 725–727, 2007. View at Google Scholar
  26. S. N. Peerayeh, A. Azimian, Q. B. Nejad, and M. Kashi, “Prevalence of agr specificity groups among Staphylococcus aureus isolates from university hospitals in Tehran,” Laboratory Medicine, vol. 40, no. 1, pp. 27–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. C. Enright, N. P. J. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt, “Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus,” Journal of Clinical Microbiology, vol. 38, no. 3, pp. 1008–1015, 2000. View at Google Scholar · View at Scopus
  28. D. Harmsen, H. Claus, W. Witte et al., “Typing of methicillin-resistant Staphylococcus aureus in a University hospital setting by using novel software for spa repeat determination and database management,” Journal of Clinical Microbiology, vol. 41, no. 12, pp. 5442–5448, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. S.-Y. Lin, T.-C. Chen, F.-J. Chen et al., “Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center,” Journal of Microbiology, Immunology and Infection, vol. 45, no. 6, pp. 435–441, 2012. View at Google Scholar
  30. J. H. Song, K. Hiramatsu, Y. S. Ji et al., “Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 12, pp. 4926–4928, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Saderi, P. Owlia, Z. Maleki, M. Habibi, and N. Rahmati, “Susceptibility to vancomycin in Staphylococcus aureus isolated from patients of four university-affiliated hospitals in Tehran,” Iran Journal of Pathology, vol. 3, no. 3, pp. 161–166, 2008. View at Google Scholar
  32. P. R. Hsueh, S. Y. Lee, C. L. Perng, T. Y. Chang, and J. J. Lu, “Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital,” International Journal of Antimicrobial Agents, vol. 36, no. 4, pp. 307–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. A. Howe, A. Monk, M. Wootton, T. R. Walsh, and M. C. Enright, “Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages,” Emerging Infectious Diseases, vol. 10, no. 5, pp. 855–857, 2004. View at Google Scholar · View at Scopus
  34. S. K. Fridkin, J. Hageman, L. K. McDougal et al., “Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997–2001,” Clinical Infectious Diseases, vol. 36, no. 4, pp. 429–439, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. C. J. Graber, M. K. Wong, H. A. Carleton, F. Perdreau-Remington, B. L. Haller, and H. F. Chambers, “Intermediate vancomycin susceptibility in a community-associated MRSA clone,” Emerging Infectious Diseases, vol. 13, no. 3, pp. 491–493, 2007. View at Google Scholar · View at Scopus
  36. L. D. Saravolatz, J. Pawlak, L. B. Johnson, L. D. Saravolatz, and N. Husain, “In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA),” International Journal of Antimicrobial Agents, vol. 36, no. 5, pp. 478–480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Sakoulas, G. M. Eliopoulos, R. C. Moellering et al., “Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 5, pp. 1492–1502, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Verdier, M. E. Reverdy, J. Etienne, G. Lina, M. Bes, and F. Vandenesch, “Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 3, pp. 1024–1027, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Shahsavan, L. Jabalameli, P. Maleknejad et al., “Molecular analysis and antimicrobial susceptibility of methicillin resistant Staphylococcus aureus in one of the hospitals of Tehran University of Medical Sciences: high prevalence of sequence type 239 (ST239) clone,” Acta Microbiologica et Immunologica Hungarica, vol. 58, no. 1, pp. 31–39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. K. S. Ko, J. Y. Lee, Y. S. Ji et al., “Distribution of major genotypes among methicillin-resistant Staphylococcus aureus clones in Asian countries,” Journal of Clinical Microbiology, vol. 43, no. 1, pp. 421–426, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Chen, Y. Liu, X. Jiang, M. Chen, and H. Wang, “Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese Tertiary Care Hospital over a 15-year period,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 5, pp. 1842–1847, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Y. Cha, H. O. Kim, J. S. Jin, and J. C. Lee, “Emergence of vancomycin-intermediate Staphylococcus aureus from predominant methicillin-resistant S. aureus clones in a Korean hospital,” Journal of Microbiology, vol. 48, no. 4, pp. 533–535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Y. Wang, S. Y. Lee, T. S. Chiueh, and J. J. Lu, “Molecular and phenotypic characteristics of methicillin-resistant and vancomycin-intermediate Staphylococcus aureus isolates from patients with septic arthritis,” Journal of Clinical Microbiology, vol. 47, no. 11, pp. 3617–3623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. L. K. McDougal, C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover, “Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database,” Journal of Clinical Microbiology, vol. 41, no. 11, pp. 5113–5120, 2003. View at Publisher · View at Google Scholar · View at Scopus